His work focusses on establishing new biomarkers of these conditions using state-of-the-art imaging and functional assessment of the eye, which are used in clinical trials to expedite the discovery of new treatments. These biomarkers are also developed to enable the earlier detection of these conditions and their progression, prediction of vision loss, and the uncovering new insights about what causes these conditions. His research is undertaken in collaboration with researchers and industry both nationally and internationally.